The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

“Non-steroidal anti-inflammatory drugs, or NSAIDs, like ibuprofen, and naproxen and Motrin, treat actual inflammation,” Brown ...

Lower-back pain affects everyone at some point, but having it on one side may unnerve you. Luckily, there are ways to treat ...

Battling a head cold and migraine at the same time is exhausting and hard to avoid. A few essential items make all the ...

NSAIDs Lead the Pain Management Market, Antimigraine Segment Set for Rapid Growth In 2023 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) segment dominated the pain management market, occupying a 34% ...

defined as pain lasting 12 weeks or longer, depends on the underlying cause. For example, for musculoskeletal issues and inflammation, anti-inflammatory medications, ice, heat, and stretching can ...

Warning over popular medication. Picture ... research is now needed to confirm our findings, given its minimal pain-relief effect, the use of paracetamol as a first-line pain killer for long ...